For: | Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ. Prognostic factors in patients with middle and distal bile duct cancers. World J Gastroenterol 2014; 20(21): 6658-6665 [PMID: 24914391 DOI: 10.3748/wjg.v20.i21.6658] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i21/6658.htm |
Number | Citing Articles |
1 |
Sun-Young Jun, Soyeon An, You-Na Sung, Yejong Park, Jae Hoon Lee, Dae Wook Hwang, Seung-Mo Hong. Clinicopathologic and Prognostic Significance of Gallbladder and Cystic Duct Invasion in Distal Bile Duct Carcinoma. Archives of Pathology & Laboratory Medicine 2020; 144(6): 755 doi: 10.5858/arpa.2019-0218-OA
|
2 |
Leva Gorji, Eliza W. Beal. Surgical Treatment of Distal Cholangiocarcinoma. Current Oncology 2022; 29(9): 6674 doi: 10.3390/curroncol29090524
|
3 |
Bingmin Li, Haowen Tang, Aiqun Zhang, Jiahong Dong, Kwan Man. Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis. PLOS ONE 2016; 11(6): e0157878 doi: 10.1371/journal.pone.0157878
|
4 |
Kosuke Jikei, Tomoki Ebata, Takashi Mizuno, Takanori Kyokane, Hideo Matsubara, Shinya Yokoyama, Kenji Kato, Kiyoshi Suzumura, Mizuo Hashimoto, Satoru Kawai, Masato Nagino, T. Aoba, Y. Kaneoka, T. Arai, Y. Shimizu, G. Sugawara, H. Miyake, E. Sakamoto, K. Shirai, Y. Okada, E. Hayashi, Y. Kato, R. Yamaguchi, S. Kobayashi, Y. Uno, T. Maeta, S. Mizuno, H. Yamamoto, K. Akashi, M. Takano, M. Uno, M. Hattori. Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma. Annals of Surgical Oncology 2021; 28(4): 1990 doi: 10.1245/s10434-020-09157-3
|
5 |
A. Marthe Schreuder, Anton F. Engelsman, Stijn van Roessel, Joanne Verheij, Marc G. Besselink, Thomas M. van Gulik, Olivier R. Busch. Treatment of mid-bile duct carcinoma: Local resection or pancreatoduodenectomy?. European Journal of Surgical Oncology 2019; 45(11): 2180 doi: 10.1016/j.ejso.2019.06.032
|
6 |
Masayuki Akita, Eri Maeda, Ryo Ishida, Tatsuya Morikawa, Tohru Nishimura, Koichiro Abe, Akihito Kozuki, Tomohiro Tanaka, Yukihiro Imai, Kunihiko Kaneda. Aggressive behavior of anaplastic undifferentiated carcinoma arising from the hilar bile duct. Surgical Case Reports 2022; 8(1) doi: 10.1186/s40792-022-01368-y
|
7 |
Yasuhiro Ito, Yuta Abe, Tomohisa Egawa, Minoru Kitago, Osamu Itano, Yuko Kitagawa. Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6431254
|
8 |
Young Saing Kim, In Gyu Hwang, Song-Ee Park, Se-Il Go, Jung-Hun Kang, Inkeun Park, Sung Yong Oh, Jun Ho Ji, Haa-Na Song, Se Hoon Park, Seung Tae Kim, Joon Oh Park. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Cancer Chemotherapy and Pharmacology 2016; 77(5): 979 doi: 10.1007/s00280-016-3014-x
|
9 |
Takeshi Nishi, Yoshitoshi Sato, Takuya Hanaoka, Takuya Takahashi, Hiroshi Miura, Kenji Takubo. Synchronous double primary cancers of the extrahepatic bile duct: A case report and literature review. International Journal of Surgery Case Reports 2018; 47: 48 doi: 10.1016/j.ijscr.2018.04.020
|
10 |
Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution. Cancer Research and Treatment 2017; 49(2): 473 doi: 10.4143/crt.2016.166
|
11 |
Hiroki Hayashi, Jin‐Young Jang, Kyung Sik Kim, Jin Sub Choi, Takeshi Takahara, Sung Hoon Choi, Satoshi Hirano, Hee Chul Yu, Syuichiro Uemura, Michiaki Unno. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi‐center collaborating study of Japan and Korea. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(6): 289 doi: 10.1002/jhbp.724
|
12 |
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted Oncology 2023; 18(1): 51 doi: 10.1007/s11523-022-00942-6
|
13 |
So Jeong Yoon, Seung Soo Hong, Min Jae Gwon, Sang Hyun Shin, Jin Seok Heo, Chang Moo Kang, Kyung Sik Kim, Ho Kyoung Hwang, In Woong Han. Effect of local treatment in patients with oligo‐recurrence after surgery of distal bile duct cancer: A bi‐institutional study. Cancer Medicine 2023; 12(10): 11274 doi: 10.1002/cam4.5836
|
14 |
Jason Ho, Steven A. Curley. Gastrointestinal Malignancies. Cancer Treatment and Research 2016; : 121 doi: 10.1007/978-3-319-34244-3_7
|
15 |
Hideyuki Takata, Atsushi Hirakata, Hiroshi Makino, Tadashi Yokoyama, Hiroyasu Furuki, Satoshi Mizutani, Akira Katsuno, Nobuhiko Taniai, Hiroshi Yoshida. Two synchronous pseudoaneurysms after bile duct resection for distal cholangiocarcinoma. Clinical Journal of Gastroenterology 2022; 15(6): 1151 doi: 10.1007/s12328-022-01711-8
|
16 |
Weiwen Zhou, Liwen Qian, Yi Rong, Qiong Zhou, Jingjing Shan, Ping Li, Liming Shi, Hai Liu, Xiaonan Sun. Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma. Radiotherapy and Oncology 2020; 147: 111 doi: 10.1016/j.radonc.2020.03.017
|
17 |
Naru Kim, Huisong Lee, Seog Ki Min, Hyeon Kook Lee. Bile duct segmental resection versus pancreatoduodenectomy for middle and distal common bile duct cancer. Annals of Surgical Treatment and Research 2018; 94(5): 240 doi: 10.4174/astr.2018.94.5.240
|
18 |
Alberto Lasagni, Mario Strazzabosco, Maria Guido, Luca Fabris, Massimiliano Cadamuro. Diseases of the Liver and Biliary Tree. 2021; : 231 doi: 10.1007/978-3-030-65908-0_14
|
19 |
O. Beetz, K. Timrott. Operative Therapie des intra- und extrahepatischen cholangiozellulären Karzinoms. Der Onkologe 2022; 28(4): 299 doi: 10.1007/s00761-022-01116-9
|
20 |
Eisuke Mukaida, Akio Tamura, Kenichi Kato, Yoshitaka Ota, Satoshi Kasugai, Hirokatsu Katagiri, Hiroyuki Nitta, Nishiya Masao, Naoki Yanagawa, Kunihiro Yoshioka. Improved Diagnosis of Adjacent Organ Invasion of Extrahepatic Cholangiocarcinoma by Adding Arterial and Delayed Phases. Cureus 2023; doi: 10.7759/cureus.47568
|
21 |
Yanming Zhou, Shuncui Liu, Lupeng Wu, Tao Wan. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian Journal of Surgery 2017; 40(2): 129 doi: 10.1016/j.asjsur.2015.07.002
|
22 |
言雄 王. Research Progress in Perineural Invasion of Perihilar Cholangiocarcinoma. Advances in Clinical Medicine 2023; 13(09): 14054 doi: 10.12677/ACM.2023.1391966
|
23 |
Yoji Miyahara, Shida Takashi, Yoshiaki Shimizu, Masayuki Ohtsuka. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01847-2
|
24 |
Soo Yeun Lim, Hani Jassim Alramadhan, HyeJeong Jeong, Hochang Chae, Hyeong Seok Kim, So Jeong Yoon, Sang Hyun Shin, In Woong Han, Jin Seok Heo, Hongbeom Kim. Survival Comparison of Different Operation Types for Middle Bile Duct Cancer: Bile Duct Resection versus Pancreaticoduodenectomy Considering Complications and Adjuvant Treatment Effects. Cancers 2024; 16(2): 297 doi: 10.3390/cancers16020297
|
25 |
Ji Hye Jung, So Jeong Yoon, Ok Joo Lee, Sang Hyun Shin, In Woong Han, Jin Seok Heo. Surgical outcomes and prognostic factors of distal common bile duct adenocarcinoma: chronological analysis in a single high-volume institutional experience. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01649-1
|
26 |
Jie He, Yuanyuan Huang, Na Huang, Jiaqing Jiang. Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1363843
|
27 |
Andrew M. Fleming, Alisa L. Phillips, Leah E. Hendrick, Justin A. Drake, Paxton V. Dickson, Evan S. Glazer, David Shibata, Sean P. Cleary, Danny Yakoub, Jeremiah L. Deneve. Segmental bile duct resection versus pancreatoduodenectomy for middle and distal third bile duct cancer. A systematic review and meta-analysis of comparative studies. HPB 2023; 25(11): 1288 doi: 10.1016/j.hpb.2023.06.012
|
28 |
K Komaya, T Ebata, K Shirai, S Ohira, N Morofuji, A Akutagawa, R Yamaguchi, M Nagino, T Aoba, Y Kaneoka, T Arai, Y Shimizu, Y Fukami, E Sakamoto, H Miyake, D Takara, Y Tojima, T Kawahara, S Mizuno, N Matsumoto, S Ota, M Takano, H Yamamoto, M Inoue, Y Asaba, T Watanabe, M Hashimoto, S Kawai, K Ikuta, H Matsubara, S Kondo. Recurrence after resection with curative intent for distal cholangiocarcinoma. British Journal of Surgery 2017; 104(4): 426 doi: 10.1002/bjs.10452
|
29 |
David Irwin. Update on Cholangiocarcinoma. Digestive Disease Interventions 2022; 6(03): 209 doi: 10.1055/s-0042-1751238
|
30 |
Tatsuo Shimura, Yasuhide Kofunato, Ryo Okada, Rei Yashima, Yoshihisa Koyama, Kenichiro Araki, Hiroyuki Kuwano, Seiichi Takenoshita. Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncology Letters 2017; 14(1): 819 doi: 10.3892/ol.2017.6252
|
31 |
Adrian Bartos, Andrei Herdean, Dana Monica Bartos. Bile Duct Cancer. 2019; doi: 10.5772/intechopen.85366
|
32 |
T Maeta, T Ebata, E Hayashi, T Kawahara, S Mizuno, N Matsumoto, S Ohta, M Nagino, T Aoba, Y Kaneoka, T Arai, Y Shimizu, M Kiriyama, E Sakamoto, H Miyake, D Takara, K Shirai, S Ohira, N Morofuji, A Akutagawa, R Yamaguchi, M Takano, H Yamamoto, M Inoue, Y Asaba, T Watanabe, M Hashimoto, S Kawai, K Ikuta, H Matsubara, K Kato, S Kondo. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma. British Journal of Surgery 2017; 104(11): 1549 doi: 10.1002/bjs.10596
|
33 |
Seoung Hoon Kim. Metachronous pancreatic cancer 18 years after resection of common bile duct cancer: A case report. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.851524
|
34 |
Lauren M. Postlewait, Cecilia G. Ethun, Nina Le, Timothy M. Pawlik, Stefan Buettner, George Poultsides, Thuy Tran, Kamran Idrees, Chelsea A. Isom, Ryan C. Fields, Bradley Krasnick, Sharon M. Weber, Ahmed Salem, Robert C.G. Martin, Charles Scoggins, Perry Shen, Harveshp D. Mogal, Carl Schmidt, Eliza Beal, Ioannis Hatzaras, Gerardo Vitiello, Kenneth Cardona, Shishir K. Maithel. Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB 2016; 18(10): 793 doi: 10.1016/j.hpb.2016.07.009
|
35 |
Jung Ho Im, Joon Seong Park, Dong Sup Yoon, Dong Ki Lee, Jun Won Kim, Ik Jae Lee. Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41622-2
|
36 |
Atsuro Fujinaga, Teijiro Hirashita, Yuka Hirashita, Kumiko Sakai, Masahiro Kawamura, Takashi Masuda, Yuichi Endo, Masayuki Ohta, Kazunari Murakami, Masafumi Inomata. Glucose metabolic upregulation via phosphorylation of S6 ribosomal protein affects tumor progression in distal cholangiocarcinoma. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02815-2
|
37 |
Yo-Han Park, Sang Hyuk Seo, Min Sung An, HyungJoo Baik, Chan Ho Lee. Prognostic Impact of Resection Margin Length in Patients Undergoing Resection for Mid-Common Bile Duct Cancer: A Single-Center Experience. Digestive Surgery 2021; 38(3): 212 doi: 10.1159/000513563
|
38 |
Adeel S. Khan, Leigh Anne Dageforde. Cholangiocarcinoma. Surgical Clinics of North America 2019; 99(2): 315 doi: 10.1016/j.suc.2018.12.004
|
39 |
Massimiliano Cadamuro, Alberto Lasagni, Angela Lamarca, Laura Fouassier, Maria Guido, Samantha Sarcognato, Enrico Gringeri, Umberto Cillo, Mario Strazzabosco, Jose JG Marin, Jesus M Banales, Luca Fabris. Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic. Expert Opinion on Investigational Drugs 2021; 30(4): 377 doi: 10.1080/13543784.2021.1880564
|